RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
10.1038/leu.2017.40
Saved in:
Main Authors: | Selvarajan, V, Osato, M, Nah, GSS, Yan, J, Chung, T-H, Voon, DC-C, Ito, Y, Ham, MF, Salto-Tellez, M, Shimizu, N, Choo, S-N, Fan, S, Chng, W-J, Ng, S-B |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Language: | English |
Published: |
NATURE PUBLISHING GROUP
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206148 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
The In vitro study of epstein-Barr Virus (EBV) infection to human primary T-Lymphocytes
by: Putrada Ninla-aesong
Published: (2010) -
Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines
by: Hosoi, Hiroki, et al.
Published: (2023) -
RUNX3 functions as an oncogene in ovarian cancer
by: Lee, C.W.L., et al.
Published: (2014) -
Epstein Barr virus infection with unusual pneumothorax: a case report
by: Piyachat Lekhanont, et al.
Published: (2006) -
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
by: Ng, Siok-Bian, et al.
Published: (2021)